142
Participants
Start Date
November 30, 2009
Primary Completion Date
December 31, 2010
Study Completion Date
September 30, 2011
Lapatinib Vinorelbine
The starting dose of vinorelbine is 25 mg/m2/ IV days 1 and 8, every 21 days. A daily dose of Lapatinib is 5 tablets (1250 mg of Lapatinib) taken approximately at the same time each day.
Lapatinib Capecitabine
The starting dose of capecitabine is 2000 mg/m2/day, to be divided and given twice daily orally, 12 hours apart, for 14 days, every 21 days. A daily dose of Lapatinib is 5 tablets (1250 mg of Lapatinib) taken approximately at the same time each day.
Gemcitabine Lapatinib
The starting dose of gemcitabine is 1000mg/m2/ IV days 1 and 8, every 21 days. A daily dose of Lapatinib is 5 tablets (1250 mg of Lapatinib) taken approximately at the same time each day.
Dr. Gustavo Ismael, Jaú
Dr. Guillermo Lerzo, Buenos Aires
Dr. Eduardo Richardet, Córdoba
Dr. Adolfo Capó, Mendoza
Dr. Juan Lacava, Neuquén
Dra. Mirta Varela, Quilmes
Dr. Luis Fein, Rosario
Dr. Jose Zarba, San Miguel de Tucumán
Dr. Cesar Blajman, Santa Fe
Dra. Silvia Neciosup, Lima
Dr. Carlos Alberto Sampaio, Salvador
Dr. José Bines, Rio de Janeiro
Dr. Carlos Barrios, Porto Alegre
Dra. Yeni Veronica Neron, Florianópolis
Dra. Patricia Xavier Santi, Santo André
Dr. Max Mano, São Paulo
Dr. Marcello Fanelli, São Paulo
Dra. Célia Tosselo de Oliveira, São Paulo
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Latin American Cooperative Oncology Group
OTHER